Hoth Therapeutics, Inc.
HOTH
$1.20
$0.065.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -86.67% | 36.72% | -45.86% | -6.91% | -30.34% |
| Total Depreciation and Amortization | -251.16% | 95.45% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,458.52% | -95.72% | 213,980.00% | -99.82% | 3,890.14% |
| Change in Net Operating Assets | 299.47% | 41.14% | -209.20% | 13.92% | 179.26% |
| Cash from Operations | -5.05% | 14.89% | -37.48% | -24.07% | -2.70% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,931.01% | -99.06% | 566.26% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,362.18% | -99.06% | 566.26% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -128.57% | 800.00% | 96.99% | -764.00% | 56.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 49.37% | -153.84% | 534.89% | 39.72% | -178.01% |